… This study concluded that erlotinib in combination with … In a Phase II trial, celecoxib was
combined with carboplatin … 13 randomized Phase III clinical trials where the biological …

… Celecoxib optimal biological dose 600 mg bid (maximal urinary decrease of PGE-M without
toxicity) + Erlotinib … ICH determination of RRM1 protein (involved in nucleotide excision repair…

… An increased understanding of the biology of lung cancer has … , gefitinib and erlotinib were
combined with chemotherapy early in … administered with the COX-2 inhibitor celecoxib (22). A …

… on how these mutations affect the biology of lung cancer, it is possible that we may be … study
(1) erlotinib plus chemotherapy in combination with radiation and (2) erlotinib plus celecoxib…

… of C225 and low-dose celecoxib may result in a more … determine the levels of PGE 2 in
CAL-27 and Fadu cells treated with … and erlotinib) for NSCLC and head and neck cancer [35], [36]…

… A phase I trial to determine the optimal biological dose of celecoxib when combined with
erlotinib in advanced non-small cell lung cancer. Clinical …

… aimed at determining the biologically-optimal dose may be … NSCLC combining erlotinib
with polychemotherapy (carboplatin … of a phase II trial of docetaxel plus celecoxib in pretreated …

… et al performed a Phase II trial of gefitinib plus celecoxib, a … of combining erlotinib and c-Met
TKIs, the combination of … versus erlotinib in patients with advanced non-small-cell lung cancer…

… A phase I study evaluated erlotinib alongside two … with locally advanced NSCLC who received
celecoxib at doses up to … enhanced by cisplatin in stage III non-small cell lung cancer. Int J …

… The other is a phase I study evaluating rosuvastatin with erlotinib in patient … phase II trial
evaluating celecoxib 400 mg oral bid in combination with gefitinib 250 mg oral daily in advanced-…